Sore Muscle And Joint Relief

Muscle And Joint Remedy


Vitaltiy Works, Inc.
Human Otc Drug
NDC 64616-111
Sore Muscle And Joint Relief also known as Muscle And Joint Remedy is a human otc drug labeled by 'Vitaltiy Works, Inc.'. National Drug Code (NDC) number for Sore Muscle And Joint Relief is 64616-111. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Sore Muscle And Joint Relief drug includes Arnica Montana - 30 [hp_C]/mL Bryonia Alba Root - 30 [hp_C]/mL Lactic Acid, L- - 30 [hp_C]/mL Matricaria Recutita - 30 [hp_C]/mL Potassium Iodide - 30 [hp_C]/mL Pulsatilla Vulgaris - 30 [hp_C]/mL Toxicodendron Pubescens Leaf - 30 [hp_C]/mL Zinc Oxide - 30 [hp_C]/mL . The currest status of Sore Muscle And Joint Relief drug is Active.

Drug Information:

Drug NDC: 64616-111
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Sore Muscle And Joint Relief
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Muscle And Joint Remedy
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Vitaltiy Works, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ARNICA MONTANA - 30 [hp_C]/mL
BRYONIA ALBA ROOT - 30 [hp_C]/mL
LACTIC ACID, L- - 30 [hp_C]/mL
MATRICARIA RECUTITA - 30 [hp_C]/mL
POTASSIUM IODIDE - 30 [hp_C]/mL
PULSATILLA VULGARIS - 30 [hp_C]/mL
TOXICODENDRON PUBESCENS LEAF - 30 [hp_C]/mL
ZINC OXIDE - 30 [hp_C]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 04 Apr, 2013
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 13 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Vitaltiy Works, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0040232024979
UPC stands for Universal Product Code.
UNII:O80TY208ZW
T7J046YI2B
F9S9FFU82N
G0R4UBI2ZZ
1C4QK22F9J
I76KB35JEV
6IO182RP7A
SOI2LOH54Z
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:Copper Absorption Inhibitor [EPC]
Decreased Copper Ion Absorption [PE]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
64616-111-0130 mL in 1 BOTTLE, DROPPER (64616-111-01)04 Apr, 2013N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Sore muscle & joint relief aids in relieving of pain from muscles and joints.

Product Elements:

Sore muscle and joint relief muscle and joint remedy glycerin arnica montana arnica montana bryonia alba root bryonia alba root matricaria recutita matricaria recutita water potassium iodide iodide ion pulsatilla vulgaris pulsatilla vulgaris toxicodendron pubescens leaf toxicodendron pubescens leaf lactic acid, l- lactic acid, l- zinc oxide zinc cation

Indications and Usage:

Sore muscle & joint relief for temporary relief of joint and muscle pains.

Warnings:

Sore muscle & joint relief if symtoms persist, discontinue use and consult a physician. if pregnant or nursing, consult physician before use.

Dosage and Administration:

Sore muscle & joint relief for age 6+, apply full dropper under tongue. wait 20 seconds. avoid food or beverages for 15 minutes.

Package Label Principal Display Panel:

Sore muscle & joint relief label


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.